🚫FDA Denies Hearing; Jiao Debarred for Five Years from Drug Imports
Yong Sheng Jiao; Denial of Hearing; Final Debarment Order
Summary
The Food and Drug Administration (FDA or Agency) is denying a request for a hearing submitted by Yong Sheng Jiao, also known as Yongsheng Jiao and Wilson Jiao (Jiao), and is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jiao for 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Jiao was convicted of a felony under Federal law for conduct relating to the importation into the United States of any drug or controlled substance under the FD&C Act. In determining the appropriateness and period of Jiao's debarment, FDA considered the relevant factors listed in the FD&C Act. Jiao submitted a request for hearing but failed to file with the Agency information and analyses sufficient to create a basis for a hearing.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The FDA's denial of a hearing and five-year debarment of Yong Sheng Jiao directly impacts businesses involved in drug importation as it outlines regulatory consequences for felony convictions. Businesses must ensure compliance with FDA regulations to avoid similar debarment risks.